Trial Profile
Pilot simplification study to Lopinavir/ritonavir 800/200 mg monotherapy regimen once daily [Estudio PILOTO de simplificación a una pauta de Lopinavir/ritonavir 800/200 mg en monoterapia una vez al día].
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 11 Oct 2016
Price :
$35
*
At a glance
- Drugs Lopinavir/ritonavir (Primary)
- Indications HIV-1 infections
- Focus Therapeutic Use
- Acronyms KMON
- 14 Dec 2015 Status changed from recruiting to completed as results published in the Antiviral Therapy.
- 14 Dec 2015 Results published in the Antiviral Therapy
- 24 Apr 2012 New trial record